Amritanshu Khaitan, MD of Eveready Industries spoke to CNBC-TV18 on the fineprint and outlook for FY22. He expects the company to become a net zero-debt firm by next year.
The firm is fairly comfortable with the debt-to-equity ratio currently, he further stated.
Khaitan also noted that the battery segment is expected to grow by 7-8 percent in the current year.
"With lot of medical equipment, the demand for AAA batteries is seeing a very healthy double-digit growth. Especially thermos scan and oximeter are two new categories which are driving battery demand,” he stated
On margins, he said, “As a category, we have achieved 25 percent EBITDA margins and our aim is to maintain those margins going forward in the current year.”
For full management commentary, watch the video.